PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1421546
PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1421546
Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029
REPORT OVERVIEW
This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.
The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITION
Erectile dysfunction (ED) is the condition that is a persistent or recurrent inability to attain and maintain penile erection sufficient to permit satisfactory sexual activity and intercourse. ED is commonly referred to as impotence and is considered one of the most common male sexual health disorders.
KEY HIGHLIGHTS
- The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%. The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.
- In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.
- Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.
- The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.
- Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.
- Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.
VENDORS LIST
- Bayer
- Pfizer
- Coloplast
- Eli Lilly and Company
- Boston Scientific
- Teva Pharma
- Viatris
- Dong-A Socio
- Vivus
- Cristalia
- Dr.Reddy's
- Aurobindo
- Seelos Therapeutics
- Menarini Group
- GSK plc
- Futura Medical
- Sanofi
- Cipla
- Lupin
- Advanz Pharma
- Sandoz
- IX Biopharma
- Domier Medtech
- Zephyr Surgical Implants
- Augusta Medical Systems
- Metuchen Pharmaceuticals
- SK Chemicals
- Endo International
- Ferring Pharmaceuticals
- Alembic Pharmaceuticals
- Guangzhou Pharmaceuticals
- Launch Medical
- Bonro Medical
- Owen Mumford
- Direx Group
- Zimmer Medizin Systems
- MTS Medical UG
- Medispec
- Inceler Medical
- NOVAmedtek
- Wikkon
- Top Quality Group
- Promedon
- Timm Medical Technologies
- Global Life Technologies
- Urology Health Store
- Hims
REPORT HIGHLIGHTS
PRODUCT SEGMENTATION & FORECAST
- Product type
Drugs
Route of Administration
- Oral Drugs
- Penile Injections
- Topical Drugs
Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Portals
Devices
Type
- Penile Implants
- Vacuum Construction Devices
- Shock Wave Therapy
- Others
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of ED Treatment Market
- Key Vendors
- Other Prominent Vendors
APPENDIX
- Research Methodology
- Abbreviations
- About Arizton
TABLE OF CONTENTS
CHAPTER - 1: ED Treatment Market Overview
- Executive Summary
- Key Findings
CHAPTER - 2: ED Treatment Market
- GLOBAL: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
CHAPTER - 3: ED Treatment Market Segmentation Data
- GLOBAL: Projected Revenue by Product type (2022-2028; $ Millions)
Drugs
Route of Administration
- Oral Drugs
- Penile Injections
- Topical Drugs
Distribution Channels
- Retail Stores
- Hospital Pharmacies
- Online Portals
Devices
Type
- Penile Implants
- Vacuum Construction Devices
- Shock Wave Therapy
- Others
CHAPTER - 4: Key Regions Overview
- North America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in US
- Projected Revenue of ED Treatment Market in Canada
- Europe: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in UK
- Projected Revenue of ED Treatment Market in Germany
- Projected Revenue of ED Treatment Market in France
- Projected Revenue of ED Treatment Market in Italy
- Projected Revenue of ED Treatment Market in Spain
- APAC: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in Japan
- Projected Revenue of ED Treatment Market in China
- Projected Revenue of ED Treatment Market in India
- Latin America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in Brazil
- Projected Revenue of ED Treatment Market in Mexico
- Projected Revenue of ED Treatment Market in Argentina
- Middle East & Africa: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in Saudi Arabia
- Projected Revenue of ED Treatment Market in South Africa
- Projected Revenue of ED Treatment Market in Turkey
CHAPTER - 5: ED Treatment Market Prospects & Opportunities
- ED Treatment Market Opportunities & Trends
- ED Treatment Market Drivers
- ED Treatment Market Constraints
CHAPTER - 6: ED Treatment Industry Overview
- ED Treatment Market - Competitive Landscape
- ED Treatment Market - Key Vendor Profiles
- ED Treatment Market - Other Prominent Vendors
- ED Treatment Market - Key Strategic Recommendations
CHAPTER - 7: Appendix
- Research Methodology
- Abbreviations
- About Arizton
List Of Exhibits
LIST OF EXHIBITS
Exhibit 1: Projected Revenues of ED Treatment in Global (2023-2029; $ Mn)
Exhibit 2: Projected Revenue of ED Treatment by Drugs (2023-2029; $ Mn)
Exhibit 3: Projected Revenue of ED Treatment by Oral Drugs ($ Mn)
Exhibit 4: Projected Revenues of ED Treatment by Penile Injections (2023-2029; $ Mn)
Exhibit 5: Projected Revenues of ED Treatment by Topical Drugs (2023-2029; $ Mn)
Exhibit 6: Projected Revenues of ED Treatment by Retail Stores (2023-2029; $ Mn)
Exhibit 7: Projected Revenues of ED Treatment by Hospital Pharmacies (2023-2029; $ Mn)
Exhibit 8: Projected Revenues of ED Treatment by Online Portals (2023-2029; $ Mn)
Exhibit 9: Projected Revenue of ED Treatment by Devices (2023-2029; $ Mn)
Exhibit 10: Projected Revenues of ED Treatment by Penile Implants (2023-2029; $ Mn)
Exhibit 11: Projected Revenues of ED Treatment by Vacuum Construction Devices
(2023-2029; $ Mn)
Exhibit 12: Projected Revenues of ED Treatment by Shock Wave Therapy (2023-2029; $ Mn)
Exhibit 13: Projected Revenues of ED Treatment by Others (2023-2029; $ Mn)
Exhibit 14: Projected Revenues of ED Treatment in North America (2023-2029; $ Mn)
Exhibit 15: Projected Revenues of ED Treatment in US (2023-2029; $ Mn)
Exhibit 16: Projected Revenues of ED Treatment in Canada (2023-2029; $ Mn)
Exhibit 17: Projected Revenues of ED Treatment in Europe (2023-2029; $ Mn)
Exhibit 18: Projected Revenues of ED Treatment in UK (2023-2029; $ Mn)
Exhibit 19: Projected Revenues of ED Treatment in Germany (2023-2029; $ Mn)
Exhibit 20: Projected Revenues of ED Treatment in France (2023-2029; $ Mn)
Exhibit 21: Projected Revenues of ED Treatment in Italy (2023-2029; $ Mn)
Exhibit 22: Projected Revenues of ED Treatment in Spain (2023-2029; $ Mn)
Exhibit 23: Projected Revenues of ED Treatment in APAC (2023-2029; $ Mn)
Exhibit 24: Projected Revenues of ED Treatment in Japan (2023-2029; $ Mn)
Exhibit 25: Projected Revenues of ED Treatment in China (2023-2029; $ Mn)
Exhibit 26: Projected Revenues of ED Treatment in India (2023-2029; $ Mn)
Exhibit 27: Projected Revenues of ED Treatment in Latin America (2023-2029; $ Mn)
Exhibit 28: Projected Revenues of ED Treatment in Brazil (2023-2029; $ Mn)
Exhibit 29: Projected Revenues of ED Treatment in Mexico (2023-2029; $ Mn)
Exhibit 30: Projected Revenues of ED Treatment in Argentina (2023-2029; $ Mn)
Exhibit 31: Projected Revenues of ED Treatment in MEA (2023-2029; $ Mn)
Exhibit 32: Projected Revenues of ED Treatment in Saudi Arabia (2023-2029; $ Mn)
Exhibit 33: Projected Revenues of ED Treatment in South Africa (2023-2029; $ Mn)
Exhibit 34: Projected Revenues of ED Treatment in Turkey (2023-2029; $ Mn)
List Of Tables
LIST OF TABLES
Table 1: Key Market Trends in ED Treatment Market
Table 2: Key Market Enablers in ED Treatment Market
Table 3: Key Market Constraints in ED Treatment Market
Table 4: Strategic Recommendations in ED Treatment Market
